Vital Signs Monitoring for COVID-19 Response
Donation protected
Overview
In light of the COVID-19 pandemic, there is a growing need for vital sign monitoring (VSM) equipment both domestically (in the United States) and globally. At Neopenda, we are harnessing our wealth of experience in VSM to scale up a novel, affordable solution to meet this demand.
Our neoGuard technology is a VSM system that has been carefully designed and tested in accordance with international standards for safety and efficacy, and with feedback from more than 400 health workers. The wearable neoGuard device continuously measures 4 key vital signs: pulse rate, oxygen saturation, respiration rate and temperature. Data is wirelessly transmitted to our application on a phone or a tablet where a patient can be monitored remotely or within a clinical setting. While neoGuard was initially designed to serve critically ill newborns, the Neopenda team sensed an urgent need to modify our solution for pediatric and adult patients as COVID-19 spread rapidly among communities where health systems are not prepared to deal with a pandemic of this scale.
Neopenda has already partnered with one American hospital to deploy neoGuard for the monitoring of COVID-19 positive patients, and this campaign will help us to reach many more, faster. We’re ready to meet this challenge, but we need your help. Please join team Neopenda by donating generously towards our efforts against COVID-19!
How Our Technology Will Help
Continuous VSM has long been a core tenet of specialized care among critically ill patients. In clinical practice, it contributes to increased survival-to-discharge rates, lower complication rates and shorter length of stay in hospital. In the context of COVID-19, it can save lives by enabling faster responses from medical staff and can help curb the spread of infection by quickly identifying suspected cases.
VSM equipment is recognized by the World Health Organization as an essential tool in the fight against COVID-19. Health workers and public health officials need reliable vital sign measurement data to:
1. Identify suspected COVID-19 cases for further testing
2. Map out potential hot spots
3. Monitor COVID-19+ patients for early signs of clinical deterioration
4. Effectively triage high-risk individuals
5. Assess effectiveness of treatment and disease severity
Who We Are
Neopenda is a social enterprise innovating medical technologies for where they are needed most. We’re based in Chicago, IL, USA, and Kampala, Uganda. We’re a small team of passionate engineers, public health professionals, and medical device design and production experts devoted to bringing improving access to high quality health care for underserved populations.
Learn more at www.neopenda.com.
Thank you for your support!
Here is a look our team's work assembling devices in April 2020:
In light of the COVID-19 pandemic, there is a growing need for vital sign monitoring (VSM) equipment both domestically (in the United States) and globally. At Neopenda, we are harnessing our wealth of experience in VSM to scale up a novel, affordable solution to meet this demand.
Our neoGuard technology is a VSM system that has been carefully designed and tested in accordance with international standards for safety and efficacy, and with feedback from more than 400 health workers. The wearable neoGuard device continuously measures 4 key vital signs: pulse rate, oxygen saturation, respiration rate and temperature. Data is wirelessly transmitted to our application on a phone or a tablet where a patient can be monitored remotely or within a clinical setting. While neoGuard was initially designed to serve critically ill newborns, the Neopenda team sensed an urgent need to modify our solution for pediatric and adult patients as COVID-19 spread rapidly among communities where health systems are not prepared to deal with a pandemic of this scale.
Neopenda has already partnered with one American hospital to deploy neoGuard for the monitoring of COVID-19 positive patients, and this campaign will help us to reach many more, faster. We’re ready to meet this challenge, but we need your help. Please join team Neopenda by donating generously towards our efforts against COVID-19!
How Our Technology Will Help
Continuous VSM has long been a core tenet of specialized care among critically ill patients. In clinical practice, it contributes to increased survival-to-discharge rates, lower complication rates and shorter length of stay in hospital. In the context of COVID-19, it can save lives by enabling faster responses from medical staff and can help curb the spread of infection by quickly identifying suspected cases.
VSM equipment is recognized by the World Health Organization as an essential tool in the fight against COVID-19. Health workers and public health officials need reliable vital sign measurement data to:
1. Identify suspected COVID-19 cases for further testing
2. Map out potential hot spots
3. Monitor COVID-19+ patients for early signs of clinical deterioration
4. Effectively triage high-risk individuals
5. Assess effectiveness of treatment and disease severity
Who We Are
Neopenda is a social enterprise innovating medical technologies for where they are needed most. We’re based in Chicago, IL, USA, and Kampala, Uganda. We’re a small team of passionate engineers, public health professionals, and medical device design and production experts devoted to bringing improving access to high quality health care for underserved populations.
Learn more at www.neopenda.com.
How We Will Use The Funds
Here’s what we need: Our team is raising $25k to fund completion of our R&D work for adapting the neoGuard hardware and software for use with adult patients in COVID-19 treatment. We’ll be able to build more units to equip pilots with two more hospitals.
Raising the bar: If we meet this initial goal, a total of $65k will enable us to optimize our supply chain & scale up to mass production.
Above and beyond: If we can raise $115,000, then Neopenda can produce about 250 devices to equip public hospitals throughout Uganda.
Here’s what we need: Our team is raising $25k to fund completion of our R&D work for adapting the neoGuard hardware and software for use with adult patients in COVID-19 treatment. We’ll be able to build more units to equip pilots with two more hospitals.
Raising the bar: If we meet this initial goal, a total of $65k will enable us to optimize our supply chain & scale up to mass production.
Above and beyond: If we can raise $115,000, then Neopenda can produce about 250 devices to equip public hospitals throughout Uganda.
Thank you for your support!
Here is a look our team's work assembling devices in April 2020:
Organizer
Sona Shah
Organizer
Chicago, IL